12 results found
India is blocking the adoption of the IFDA as it will set a norm sidelining developing states from the decision-making process
अमेरिकेचा बायोसिक्युअर कायदा त्या देशाच्या चीनशी असलेल
The US Biosecure Act aims to decouple its supply chains from China, presenting a huge opportunity for India’s pharma industry
Although biohacking offers opportunities for improved health, it raises significant ethical and safety concerns that need to be addressed via state re
कोविड-19 वैक्सीन और मेडिकल उपकरणों के लिए कई देश भारतीय बा�
Even as experts urge caution on the drug’s efficacy against COVID-19, production of chloroquine in India is being ramped up to cater to US demand
The knowledge base, strength and capabilities of the Indian pharma have not been appreciated and image of Indian pharma industry is constantly being m
FDA in retail is not the reform that can change the face of Indian agriculture as the problems of small farmers and their vicious cycle of poverty have to end through state action and not by big foreign retailers.
